Conference abstract
Mini reviewPublished 15 Jul 2024
Veto-Engineering Immune Tolerance
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The old veto effect may be moving from its status as an obscure immune inhibitory phenomenon to an important role on specific immune suppression. In today's clinical practice, broad suppression of the immune system is employed to avoid transplant rejection and mitigate auto-aggressive immune responses. Though highly effective, this approach impairs immune protection against infectious challenges. Therapeutic approaches are being sought that specifically inhibit sections of the immune system without affecting beneficial immune functions. One such tactic entails the classical veto-effect that employs donor-derived CD8+ T cells to inhibit cellular immune responses. Indeed, this kind of veto has already found applications as the underpinning of a more broadly applicable CAR-T cell therapy and of a more spec0069fic immune suppression for haploidentical Hematopoietic Stem Cell (HSC) transplantations. To broaden and simplify the use of veto, engineering strategies are discussed that affix its immune inhibitory function to cells of different tissues. They are based on the transfer of the CD8 α-chain to the surface of different cell populations. We predict that engineered veto will simplify specific immune suppression and broadening its application to organ transplantations and possibly the treatment of autoimmune diseases. It may represent an avenue to induce immunological tolerance.
Subjects
HaematologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 8 Nov 2017
Chimeric antigen receptors (CARs) engineered control adverse immune responses
Commentary · 21 Jun 2023
The Engineered Immunity of CAR-T Cell Therapy in Cancer Therapy
Conference abstract
Immune tolerance induction in the treatment of pediatric hemophilia A with inhibitor
Conference abstract
MiR-150 enhances immune tolerance by targeting ARRB-2/PDE4 to down-regulate inflammatory cytokines
More from this journal
The newest in Journal of Hematology & Thromboembolic Diseases.
Mini review · 13 Feb 2026
Factors Influencing Attitudes of Adults towards Hypertension Management in Nigeria: A Mini-Review
Opinion · 25 Dec 2025
Clinical Patterns and Systemic Implications of Thromboembolism
Opinion · 25 Dec 2025
Integrating Clinical Risk and Preventive Care in Thromboembolism Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Hematology & Thromboembolic Diseases
- SubjectHaematology
- BylineArticles whose byline prints “Uwe D Staerz”
- BylineArticles whose byline prints “Janae W Cull”
- BylineArticles whose byline prints “Yan Qi”

